MOTS-c 20mg
Extended Supply MOTS-c for Comprehensive Metabolic Research
The 20mg MOTS-c vial enables extended metabolic, longevity, and exercise biology research with double the compound of the entry 10mg vial.
Extended Supply MOTS-c for Comprehensive Metabolic Research
Same mitochondria-derived retrograde signaling peptide at double quantity for comprehensive AMPK/FOXO pathway and metabolic homeostasis research.
As one of the most studied compounds in the recovery & healing research space, MOTS-c has attracted sustained scientific interest across Extended metabolic research, Multi-week longevity studies. Peer-reviewed evidence indicates that 20mg supports multi-month research protocols, which has positioned MOTS-c as a reference standard for researchers exploring extended metabolic research outcomes. The compound's selectivity and documented tolerability in preclinical models have contributed to a rapidly growing body of literature over the past decade.
MOTS-c Documented Benefits: 1 Documented Mechanisms
Extended Research Supply
Double the compound for multi-week metabolic and longevity protocols.
How MOTS-c Works: Molecular Mechanism & Pathway
Same MOTS-c mitochondrial peptide AMPK/FOXO activation mechanism.
The 1 primary research pathways identified for MOTS-c — Extended Research Supply — collectively point to a compound with pleiotropic activity across interconnected biological systems. Studies have further shown that same purity as 10mg variant, reinforcing the mechanistic picture established in earlier cell-line work. Unlike single-pathway agents, MOTS-c's broad receptor engagement profile continues to generate hypotheses for novel applications beyond its originally characterized use cases.
Research Protocols & Compound Combinations
MOTS-c is routinely studied alongside MOTS-c and MOTS-c in recovery & healing-focused compound panels. Researchers investigating extended metabolic research have found that pairing compounds with complementary receptor profiles can produce additive results while keeping individual doses within well-characterized ranges. Preliminary evidence that best value for ongoing MOTS-c studies has informed several of these multi-compound protocol designs.
Purity, Testing & Research Grade Standards
All MOTS-c research material offered through this catalog is manufactured under controlled conditions and independently verified by a third-party laboratory prior to release. Each lot undergoes High-Performance Liquid Chromatography (HPLC) analysis to confirm ≥98% purity, with identity confirmed via mass spectrometry. The accompanying Certificate of Analysis (CoA) documents the exact purity, molecular weight confirmation, and lot-specific testing date — data that should accompany any reproducible research protocol. Lyophilized powder formulation ensures maximum stability during shipping and storage at −20°C long-term or 4°C for short-term use.
◈ Key Highlights
- 20mg supports multi-month research protocols
- Same purity as 10mg variant
- Best value for ongoing MOTS-c studies
Ideal For
- Extended metabolic research
- Multi-week longevity studies
Intended for laboratory use only. Not for human or animal consumption. Not FDA approved. Handle in appropriate lab settings only.
What the Research Shows
The following data points are derived from peer-reviewed preclinical and clinical studies on MOTS-c. All studies cited in compound profiles are indexed in PubMed or published in peer-reviewed journals.
20mg supports multi-month research protocols
Same purity as 10mg variant
Best value for ongoing MOTS-c studies
Third-Party Verified Every Batch
Each vial of MOTS-c is independently tested by a third-party laboratory before fulfillment. You receive the actual CoA (Certificate of Analysis) documentation with your order.
